ECVT Ecovyst Inc.
Chemicals & Allied Products · NYSE · SEC CIK 1708035 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY44.6%
TTM net income YoY133.6%
TTM EPS YoY134.4%
Revenue 3-yr CAGR11.5%
Net income 3-yr CAGR-18.4%
Margins
Gross margin19.7%
Operating margin8.5%
Net margin3.7%
FCF margin2.8%
EBITDA margin15.9%
Returns
ROE5.9%
ROA2.3%
ROIC (approx.)5.4%
Asset turnover0.62x
Leverage & solvency
Liabilities / assets57.2%
Debt / equity0.81x
Current ratio1.82x
Interest coverage3.73x
Cash quality & payout
Operating cash flow / net income3.28x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue9.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q42025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $308.64M | $249.96M | $214.95M | $199.43M | $204.91M | $176.06M | $143.11M | $148.87M |
| Cost of revenue | $249.92M | $200.12M | $178.54M | $152.68M | $152.83M | $135.90M | $124.01M | $105.88M |
| Gross profit | $58.71M | $49.85M | $36.41M | $46.75M | $52.08M | $40.16M | $19.10M | $42.99M |
| SG&A expense | $20.43M | $17.35M | $19.13M | $16.25M | $15.66M | $17.61M | $16.50M | $15.54M |
| Operating income | $29.25M | $19.36M | $12.54M | $21.81M | $28.27M | $15.78M | -$981,000 | $22.44M |
| Interest expense | $6.22M | $3.46M | $3.17M | $9.40M | $8.55M | $8.46M | $8.35M | $9.42M |
| Pretax income | $22.91M | $14.89M | $9.34M | $8.17M | $20.38M | $7.04M | -$10.37M | $14.79M |
| Income tax | $4.55M | $4.19M | $3.59M | -$476,000 | $20.20M | $2.02M | -$2.24M | -$8.33M |
| Net income | $18.16M | $7.87M | $4.31M | $5.74M | -$79.25M | $5.99M | -$3.60M | -$30.42M |
| EBITDA | $48.56M | $36.30M | $30.33M | $39.62M | $31.21M | $39.72M | $14.65M | $37.80M |
| EPS (basic) | 0.17 | 0.07 | 0.04 | 0.05 | -0.70 | 0.05 | -0.03 | -0.26 |
| EPS (diluted) | 0.16 | 0.07 | 0.04 | 0.05 | -0.69 | 0.05 | -0.03 | -0.26 |
| Weighted avg. shares (diluted) | 110.63M | 110.84M | 111.79M | 114.45M | 114.87M | 116.54M | 117.26M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $71.21M | $87.76M | $162.55M | $197.19M | $81.98M | $55.22M | $116.03M | $131.39M |
| Receivables | $121.26M | $112.94M | $94.10M | $85.31M | $83.27M | $103.47M | $76.94M | $53.20M |
| Inventory | $39.03M | $40.02M | $32.24M | $26.80M | $24.13M | $66.90M | $58.79M | $17.97M |
| Current assets | $247.59M | $261.36M | $304.29M | $319.36M | $297.06M | $269.41M | $291.96M | $303.71M |
| PP&E, net | $546.99M | $533.98M | $477.76M | $481.16M | $481.20M | $602.89M | $571.05M | $458.68M |
| Goodwill | $399.54M | $398.27M | $326.74M | $326.74M | $326.95M | $406.75M | $404.91M | $326.59M |
| Intangibles | $125.51M | $135.51M | $56.59M | $59.29M | $62.08M | $94.78M | $95.24M | $67.70M |
| Total assets | $1.42B | $1.42B | $1.25B | $1.26B | $1.73B | $1.80B | $1.79B | $1.80B |
| Current liabilities | $135.72M | $153.61M | $127.92M | $120.81M | $132.09M | $119.69M | $104.03M | $115.13M |
| Short-term debt | — | — | — | $0 | $8.73M | $8.73M | $8.73M | $8.73M |
| Long-term debt | $493.14M | $492.95M | $392.76M | $392.58M | $846.08M | $847.88M | $850.26M | $852.10M |
| Total debt | $493.14M | $492.95M | $392.76M | $392.58M | $854.81M | $856.61M | $858.99M | $860.83M |
| Total liabilities | $811.25M | $833.76M | $671.43M | $657.54M | $1.13B | $1.10B | $1.09B | $1.10B |
| Shareholders' equity | $606.25M | $586.95M | $575.18M | $603.44M | $607.87M | $692.39M | $698.68M | $700.46M |
| Net debt | $421.94M | $405.19M | $230.21M | $195.39M | $772.84M | $801.40M | $742.96M | $729.44M |
| Shares outstanding | 109.20M | 109.47M | 109.45M | 111.81M | 114.02M | 114.49M | 117.39M | 116.53M |
| Cash flow statement | ||||||||
| Operating cash flow | $25.22M | $34.35M | $16.94M | $41.76M | $55.25M | $33.04M | $10.26M | $43.49M |
| Capital expenditure | $27.86M | $30.67M | $14.14M | $18.81M | $2.07M | $22.03M | $17.09M | $12.63M |
| Free cash flow | -$2.63M | $3.68M | $2.80M | $22.94M | $53.18M | $11.01M | -$6.84M | $30.86M |
| Investing cash flow | -$39.10M | -$209.20M | -$14.14M | $543.87M | -$17.62M | -$66.59M | -$24.25M | -$17.23M |
| Financing cash flow | -$2.44M | $100.06M | -$37.44M | -$487.50M | -$8.07M | -$24.93M | -$4.45M | -$2.73M |
| Depreciation & amortization | $19.32M | $16.94M | $17.79M | $17.80M | $2.94M | $23.94M | $15.63M | $15.36M |
| Stock-based compensation | $2.42M | $2.50M | $3.43M | $2.19M | $2.27M | $2.76M | $2.52M | $2.83M |
| Share buybacks | $2.44M | $0 | $36.34M | $19.49M | $5.54M | $21.92M | $0 | $0 |
Free plan shows the latest 8 periods; Pro shows all 43 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.